Haleon Plc (HLNCF)
Haleon Market Cap : 46.08B for March 18, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Silence Therapeutics Plc | 283.40M |
| Adaptimmune Therapeutics Plc | 4.771M |
| Biodexa Pharmaceuticals Plc | 0.646M |
| Oxford Biomedica Plc | 982.08M |
| NuCana Plc | 7.242M |
Market Cap Related Metrics
| PE Ratio | 21.25 |
| PS Ratio | 3.213 |
| PEG Ratio | 0.2899 |
| Price to Free Cash Flow | 18.13 |
| Price | 5.175 |
| Earnings Yield | 4.71% |
| PEGY Ratio | 0.2831 |
| Operating PE Ratio | 14.29 |
| Normalized PE Ratio | 20.48 |